A number of independent lines of evidence converge indicating a role for ni
tric oxide (NO) in angiogenesis. Our data support the existence of an autoc
rine loop exerted by microvascular endothelium in angiogenesis which involv
es NO production, cyclic GMP elevation and fibroblast growth factor-2 (FGF-
2) expression. Our results indicate that NO production significantly contri
butes to the growth-promoting effect of vasodilating peptides and vascular
endothelial growth factor (VEGF), but not for that of FGF-2. On these basis
, the nitric oxide pathway appears to be a promising target to be considere
d in pro- and anti-angiogenic therapeutic strategies.